Skip to main content
. 2023 Mar 13;66(6):1071–1083. doi: 10.1007/s00125-023-05881-z

Table 4.

Pleiotropy in terms of gene expression in relevant tissues, protein expression, diseases and effect on transcript for variants that showed novel associations with plasma protein and IgG N-glycosylation; the most biologically plausible candidates for observed novel associations are the C3 gene due to an associated missense variant located in the coding region and the associated Man9 glycan attached to its protein product surface, and the N-glycosyltransferase gene MGAT3

Glycan Glycan structure Locus Gene SNP Number of SNPs in the interval Effect on transcript eQTL in relevant tissues/tissue pQTL; protein; tissue Disease gene (s); disease
GP19 Man9 19: 6,710,782–6,713,262 C3 rs1047286 2

Direct: rs1047286 missense coding variant, C3 protein pPro314Leu substitution

Putative: C3 rs2230203 synonymous coding variant

C8; C8; plasma C3, C8A/B/G; increased risk of type 1 diabetes among HLA-DR4/4 carriers [41]a, macular degeneration, complement component 3 deficiency, haemolytic uraemic syndrome, complement component 8 deficiency type I/II
IGP24 FA2BG2S2 22: 39,843,409–39,844,793 rs5757680 2 Intergenic region MGAT3/whole blood IL6ST (sGP130); IL-6 receptor subunit β (gp130, soluble); plasma IL6ST; hyper-IgE recurrent infection syndrome 4b
IGP15 FA2BG2 22: 39,739,638–39,756,985 SYNGR1 rs137702 7 Putative: SYNGR1 intron variants (rs137702, rs137707, rs2413589, rs4821887) MGAT3/B cells IL6ST (sGP130); IL-6 receptor subunit β (gp130, soluble); plasma IL6ST; hyper-IgE recurrent infection syndrome 4b

Each locus is represented by the SNP with the strongest association in the region. Locus information is presented as ‘chromosome number: locus start – locus end’. The results are reported for GRCh Build 37. eQTL, pQTL, disease gene/disease, effect on transcript and LD were obtained using SNiPA [35], and SNPs were grouped in the same genomic interval based on LD (R2>0.5) with the top associated SNP within the interval

ars2230199 was previously associated with an increased risk of type 1 diabetes among HLA-DR4/4 carriers (R2=0.82 with rs1047286; R2=0.7 with rs2230203)

C8A/B/G, complement C8 α/β/γ chain gene; IL6ST, interleukin 6 cytokine family signal transducer gene; gp130, soluble glycoprotein 130 (synonyms: IL6ST, soluble)